Last reviewed · How we verify
CGRP
At a glance
| Generic name | CGRP |
|---|---|
| Also known as | calcitonin-gene-related peptide |
| Sponsor | Danish Headache Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications (PHASE4)
- Effect Of Different Sodium Hypochlorite Concentrations On Intracanal Substance P, CGRP And Opiorphin Levels And Postoperative Pain During Root Canal Retreatment (NA)
- A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine (PHASE3)
- Fremanezumab, Migraine and Sleep (PHASE4)
- A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults (PHASE1)
- Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients (PHASE4)
- Paravertebral Calcitonin in Thoracotomy (NA)
- The Effect of Interventional Procedures on Serum CGRP and PACAP-38 Levels in Chronic Migraine (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CGRP CI brief — competitive landscape report
- CGRP updates RSS · CI watch RSS
- Danish Headache Center portfolio CI